Send feedback

CDC73 p.Arg441His

c.1322G>A · rs778432682 · VCV1522712

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
AlphaMissense
likely pathogenic
0.9828 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.000339%, nfe)
Missense predictors
3/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
2
parathyroid gland carcinoma

Computational evidence

Protein change
AlphaMissense0.9828likely pathogenic
REVEL0.827moderately pathogenic-leaning
SaProtLLR -12.89damaging
⇒ AlphaMissense, REVEL and SaProt all call this damaging.
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP 12GERP 1.9, phastCons 1
Regional constrainto/e 0.57unconstrained · MANE · 109 kb · p 8.5e-19 · regional, not allelic
Overall
CADD33.0PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.000339% European (non-Finnish) · 4/1,178,490 alleles
Filtering AF 7.9e-05% ClinGen BA1/BS1 input FAF95, joint · FAF99 5.4e-05%
Overall 0.00031% 5/1,612,444 alleles · very rare exomes 5/1,460,192 · genomes 0/152,252 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.00338% 29,600
European (non-Finnish)grpmax 0.000339% 294,623

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CDC73
Protein
p.Arg441His
Coding
c.1322G>A
MANE Select
NM_024529
dbSNP
rs778432682
Type
single nucleotide variant
Location
chr1:193236261 (GRCh38)
Gene constraint
LOEUF 0.42 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
Structure
AlphaFold pLDDT 73.94 · 21 PDB
Residue 441
the 'interaction with polr2a and paf1' region; an α-helix
Full CDC73 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

parathyroid gland carcinoma — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: hereditary neoplastic syndrome

For Parathyroid carcinoma (Orphanet):

Inheritance
Not applicable
Onset
Adult
Prevalence
<1 / 1 000 000 (Europe)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cdc73-p-arg441his (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown